← Back to Screener
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)
Price$2.43
Growth ScoreD
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-61.99%
Price vs S&P 500 (4W)8.49%
VGM Score35.21
Market Capitalization$1.74M
All Metrics
Book Value / Share (Quarterly)$0.26
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-4.12%
Cash Flow / Share (Quarterly)$-0.48
Price vs S&P 500 (YTD)-32.22%
Gross Margin (TTM)-0.36%
Net Profit Margin (TTM)-9118.83%
EPS (TTM)$-2.05
10-Day Avg Trading Volume0.42M
EPS Excl Extra (TTM)$-2.05
EPS (Annual)$-1.42
ROI (Annual)-89.52%
Gross Margin (Annual)-1.30%
Net Profit Margin (5Y Avg)-3306.05%
Cash / Share (Quarterly)$0.16
Revenue Growth QoQ (YoY)3.25%
ROA (Last FY)-54.95%
EBITD / Share (TTM)$-2.11
Operating Margin (TTM)-9352.76%
Cash Flow / Share (Annual)$-0.48
P/B Ratio0.57x
P/B Ratio (Quarterly)0.75x
Net Income / Employee (Annual)$-363,291
Net Interest Coverage (TTM)-39.54x
ROA (TTM)-68.80%
EPS Incl Extra (Annual)$-1.42
Current Ratio (Annual)2.35x
Quick Ratio (Quarterly)1.11x
3-Month Avg Trading Volume0.23M
52-Week Price Return-94.43%
Revenue / Employee (TTM)$5,675
P/S Ratio (Annual)57.88x
Asset Turnover (Annual)0.01x
52-Week High$76.00
Operating Margin (5Y Avg)-3433.66%
EPS Excl Extra (Annual)$-1.42
26-Week Price Return-54.06%
Quick Ratio (Annual)1.11x
13-Week Price Return-15.92%
Total Debt / Equity (Annual)0.03x
Current Ratio (Quarterly)2.35x
Enterprise Value$-50,610.435
Asset Turnover (TTM)0.01x
Revenue / Employee (Annual)$3,887
Inventory Turnover (Annual)58.43x
Pretax Margin (Annual)-9240.53%
Cash / Share (Annual)$0.16
3-Month Return Std Dev194.96%
Gross Margin (5Y Avg)20.69%
Net Income / Employee (TTM)$-516,911
ROE (Last FY)-92.44%
Net Interest Coverage (Annual)-291.09x
EPS Basic Excl Extra (Annual)$-1.42
Receivables Turnover (TTM)3.27x
Total Debt / Equity (Quarterly)0.03x
EPS Incl Extra (TTM)$-2.05
Receivables Turnover (Annual)2.24x
P/S Ratio (TTM)39.61x
Pretax Margin (5Y Avg)-3249.85%
Revenue / Share (Annual)$0.02
Price vs S&P 500 (52W)-118.79%
Year-to-Date Return-24.06%
5-Day Price Return-8.65%
EPS Normalized (Annual)$-1.42
ROA (5Y Avg)-69.14%
Net Profit Margin (Annual)-9367.51%
Month-to-Date Return1.25%
EBITD / Share (Annual)$-1.46
Operating Margin (Annual)-9680.96%
LT Debt / Equity (Annual)0.03x
LT Debt / Equity (Quarterly)0.03x
EPS Basic Excl Extra (TTM)$-2.05
P/B Ratio (Annual)0.75x
Inventory Turnover (TTM)84.59x
Pretax Margin (TTM)-8997.97%
Book Value / Share (Annual)$0.26
Price vs S&P 500 (13W)-24.17%
Beta1.32x
Revenue / Share (TTM)$0.02
52-Week Low$1.76
gGradeD
mGradeD
vgmGradeD
Show chart for
Industry Peers — Orthopedic & Prosthetic Devices(33)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares | — | D | D | $2.43 |
| ISRGIntuitive Surgical Inc. | F | B | C | $422.06 |
| EWEdwards Lifesciences Corp | D | C | C | $85.96 |
| STESTERIS plc | C | B | C | $212.35 |
| ZBHZimmer Biomet Holdings, Inc. | B | C | C | $87.33 |
| ALGNAlign Technology Inc | B | C | C | $167.74 |
| SNNSmith & Nephew plc | B | C | C | $30.61 |
| MSAMine Safety Incorporated | B | C | C | $161.30 |
| ESTAEstablishment Labs Holdings Inc. | F | A | B | $74.31 |
| ENOVEnovis Corporation | B | D | C | $23.78 |
| CDRECadre Holdings, Inc. | C | C | D | $30.01 |
About
Cuprina Holdings (Cayman) Ltd specializes in chronic wound management through its MEDIFLY product line, which uses sterile blowfly larvae as a biological debridement tool. MEDIFLY offers a clinically proven alternative to traditional surgical debridement for chronic wounds. The company also operates in the health and beauty sector.